Notice 29 Jul 2025 regulatory compliance, fda, drug development, tropical diseases, priority review vouchers

💊FDA Notice on Tropical Disease Priority Review Vouchers Collection

The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

Learn More
Notice 1 May 2025 fda, regulatory requirements, compliance, health, tropical diseases, pharmaceuticals

💊FDA Comment Request on Tropical Disease Priority Review Vouchers

The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on Tropical Disease Priority Review Vouchers.

Learn More